Regenxbio (RGNX) Receivables (2014 - 2026)
Regenxbio's Receivables came in at $128.23 million for Q2 2026, up 487.9% from $21.81 million a year earlier and up 625.5% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Receivables (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Receivables was $54.49 million, up 32.7% from FY2024.
- Receivables carries a five-year compound annual growth rate of 3.2% (FY2020 to FY2025).
- Going back by year, Receivables was $41.05 million in FY2024 (-17.3%), $49.62 million in FY2023 (-12.4%), $56.61 million in FY2022 (+58.2%) and $35.78 million in FY2021 (-23.3%).
- The Q2 2026 figure represents the highest quarterly Receivables since Q3 2020.
- Year-over-year, Receivables increased in three of the last eight quarters, with growth averaging 80.0%.
- The fastest year-over-year change in Receivables over five years came in Q2 2026 (growth of 487.9%), and the weakest in Q2 2023 (a decline of 66.4%).
- Business Quant data shows RGNX's Receivables at $17.68 million (Q1 2026), $50.46 million (Q4 2025) and $53.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - | 128.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.23 Mn |
| Dec 31, 2025 | 50.46 Mn |
| Sep 30, 2025 | 53.37 Mn |
| Jun 30, 2025 | 21.81 Mn |
| Mar 31, 2025 | 19.44 Mn |
| Dec 31, 2024 | 21.19 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Jun 30, 2024 | 23.47 Mn |
| Mar 31, 2024 | 31.66 Mn |
| Dec 31, 2023 | 30.08 Mn |
| Sep 30, 2023 | 31.12 Mn |
| Jun 30, 2023 | 24.52 Mn |
| Mar 31, 2023 | 22.16 Mn |
| Dec 31, 2022 | 56.61 Mn |
| Sep 30, 2022 | 66.75 Mn |
| Jun 30, 2022 | 73.01 Mn |
| Mar 31, 2022 | 30.23 Mn |
| Dec 31, 2021 | 35.78 Mn |
| Sep 30, 2021 | 77.73 Mn |
| Jun 30, 2021 | 69.68 Mn |
API Access
Regenxbio Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();